Next Article in Journal
Do Feelings of Defeat and Entrapment Change over Time? An Investigation of the Integrated Motivational—Volitional Model of Suicidal Behaviour Using Ecological Momentary Assessments
Previous Article in Journal
The Burden of Endometriosis on Women’s Lifespan: A Narrative Overview on Quality of Life and Psychosocial Wellbeing
Open AccessLetter

Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings

1
Department of Medicine, Columbia University, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140, USA
2
Division of Cardiology, Columbia University, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140, USA
3
Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 West 168th Street, New York, NY 10032, USA
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(13), 4684; https://doi.org/10.3390/ijerph17134684
Received: 23 April 2020 / Revised: 18 June 2020 / Accepted: 23 June 2020 / Published: 29 June 2020
(This article belongs to the Special Issue Metal Exposure and Health Risk Assessment 2020)
Environmentally acquired lead and cadmium are associated with increased cardiovascular disease risk. In the Trial to Assess Chelation Therapy, up to 40 infusions with edetate disodium over an approximately one-year period lowered the cardiovascular disease risk in patients with a prior myocardial infarction. We assessed whether a reduction in surrogate measures of total body lead and cadmium, post-edetate disodium urine lead and pre-edetate urine cadmium, could be detected after repeated edetate disodium-based infusions compared to the baseline. Fourteen patients with coronary artery disease received multiple open-label edetate disodium infusions. The urine metals pre- and post-edetate infusion, normalized for urine creatinine, were compared to urine levels pre and post final infusion by a paired t-test. Compared with the pre-edetate values, post-edetate urine lead and cadmium increased by 3581% and 802%, respectively, after the first infusion. Compared to baseline, post-edetate lead decreased by 36% (p = 0.0004). A reduction in post-edetate urine lead was observed in 84% of the patients after the final infusion. Pre-edetate lead decreased by 60% (p = 0.003). Pre-edetate lead excretion became undetectable in nearly 40% of patients. This study suggests that edetate disodium-based infusions may decrease the total body burden of lead. However, our data suggest no significant reduction in the body burden of cadmium. View Full-Text
Keywords: lead; cadmium; chelation; vascular disease; atherosclerosis lead; cadmium; chelation; vascular disease; atherosclerosis
Show Figures

Figure 1

MDPI and ACS Style

Alam, Z.H.; Ujueta, F.; Arenas, I.A.; Nigra, A.E.; Navas-Acien, A.; Lamas, G.A. Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings. Int. J. Environ. Res. Public Health 2020, 17, 4684.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop